Ivermectin inhibits HSP27 and potentiates efficacy of oncogene targeting in tumor models. [electronic resource]
- The Journal of clinical investigation 02 2020
- 699-714 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1558-8238
10.1172/JCI130819 doi
A549 Cells Animals Heat-Shock Proteins--antagonists & inhibitors Humans Intracellular Signaling Peptides and Proteins--chemistry Ivermectin--chemistry Mice Molecular Chaperones--antagonists & inhibitors Neoplasms, Experimental--drug therapy Protein Domains Protein Multimerization Protein Serine-Threonine Kinases--chemistry Receptor, ErbB-2--genetics